% alzhub.org library filter % Source: https://alzhub.org/research?author=Stomrud+E&atag=phosphorylated % 16 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{ossenkoppele2025-40155777, author = {Ossenkoppele, R. and Salvadó, G. and Janelidze, S. and Pichet Binette, A. and Bali, D. and Karlsson, L. and Palmqvist, S. and Mattsson-Carlgren, N. and Stomrud, E. and Therriault, J. and Rahmouni, N. and Rosa-Neto, P. and others}, title = {{Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials}}, journal = {Nature Aging}, year = {2025}, doi = {10.1038/s43587-025-00835-z}, pmid = {40155777}, url = {https://doi.org/10.1038/s43587-025-00835-z} } @article{pereira2021-34259835, author = {Pereira, J. B. and Janelidze, S. and Smith, R. and Mattsson-Carlgren, N. and Palmqvist, S. and Teunissen, C. E. and Zetterberg, H. and Stomrud, E. and others}, title = {{Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease}}, journal = {Brain : a journal of neurology}, year = {2021}, doi = {10.1093/brain/awab223}, pmid = {34259835}, url = {https://doi.org/10.1093/brain/awab223} } @article{palmqvist2020-32722745, author = {Palmqvist, S. and Janelidze, S. and Quiroz, Y. T. and Zetterberg, H. and Lopera, F. and Stomrud, E. and Su, Y. and Chen, Y. and others}, title = {{Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders}}, journal = {JAMA}, year = {2020}, doi = {10.1001/jama.2020.12134}, pmid = {32722745}, url = {https://doi.org/10.1001/jama.2020.12134} } @article{ossenkoppele2022-36357681, author = {Ossenkoppele, R. and Pichet Binette, A. and Groot, C. and Smith, R. and Strandberg, O. and Palmqvist, S. and Stomrud, E. and Tideman, P. and others}, title = {{Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline}}, journal = {Nature medicine}, year = {2022}, doi = {10.1038/s41591-022-02049-x}, pmid = {36357681}, url = {https://doi.org/10.1038/s41591-022-02049-x} } @article{janelidze2021-33165506, author = {Janelidze, S. and Berron, D. and Smith, R. and Strandberg, O. and Proctor, N. K. and Dage, J. L. and Stomrud, E. and Palmqvist, S. and others}, title = {{Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease}}, journal = {JAMA neurology}, year = {2021}, doi = {10.1001/jamaneurol.2020.4201}, pmid = {33165506}, url = {https://doi.org/10.1001/jamaneurol.2020.4201} } @article{mattsson2016-27694257, author = {Mattsson, N. and Zetterberg, H. and Janelidze, S. and Insel, P. S. and Andreasson, U. and Stomrud, E. and Palmqvist, S. and Baker, D. and others}, title = {{Plasma tau in Alzheimer disease}}, journal = {Neurology}, year = {2016}, doi = {10.1212/wnl.0000000000003246}, pmid = {27694257}, url = {https://doi.org/10.1212/wnl.0000000000003246} } @article{salvado2025-40952756, author = {Salvadó, G. and Janelidze, S. and Bali, D. and Dolado, A. O. and Therriault, J. and Brum, W. S. and Pichet Binette, A. and Stomrud, E. and Mattsson-Carlgren, N. and Palmqvist, S. and Coomans, E. M. and Teunissen, C. E. and others}, title = {{Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease}}, journal = {JAMA Neurology}, year = {2025}, doi = {10.1001/jamaneurol.2025.3217}, pmid = {40952756}, url = {https://doi.org/10.1001/jamaneurol.2025.3217} } @article{palmqvist2021-34031605, author = {Palmqvist, S. and Tideman, P. and Cullen, N. and Zetterberg, H. and Blennow, K. and {Alzheimer’s Disease Neuroimaging Initiative} and Dage, J. L. and Stomrud, E. and others}, title = {{Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures}}, journal = {Nature medicine}, year = {2021}, doi = {10.1038/s41591-021-01348-z}, pmid = {34031605}, url = {https://doi.org/10.1038/s41591-021-01348-z} } @article{nagga2018-29196581, author = {Nägga, K. and Gustavsson, A. M. and Stomrud, E. and Lindqvist, D. and van Westen, D. and Blennow, K. and Zetterberg, H. and Melander, O. and others}, title = {{Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later}}, journal = {Neurology}, year = {2018}, doi = {10.1212/wnl.0000000000004749}, pmid = {29196581}, url = {https://doi.org/10.1212/wnl.0000000000004749} } @article{groot2024-38857029, author = {Groot, C. and Smith, R. and Collij, L. E. and Mastenbroek, S. E. and Stomrud, E. and Binette, A. P. and Leuzy, A. and Palmqvist, S. and others}, title = {{Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment}}, journal = {JAMA neurology}, year = {2024}, doi = {10.1001/jamaneurol.2024.1612}, pmid = {38857029}, url = {https://doi.org/10.1001/jamaneurol.2024.1612} } @article{salvado2026-42189519, author = {Salvadó, G. and Horie, K. and Barthélemy, N. R. and Schindler, S. E. and Janelidze, S. and Orduña Dolado, A. and Bali, D. and Perrin, R. J. and Morris, J. C. and Benzinger, T. L. S. and Gordon, B. A. and Stomrud, E. and others}, title = {{Plasma eMTBR-tau243 and \%p-tau217 for Biological Staging of Alzheimer Disease}}, journal = {JAMA Neurology}, year = {2026}, doi = {10.1001/jamaneurol.2026.1405}, pmid = {42189519}, url = {https://doi.org/10.1001/jamaneurol.2026.1405} } @article{leuzy2021-34493616, author = {Leuzy, A. and Janelidze, S. and Mattsson-Carlgren, N. and Palmqvist, S. and Jacobs, D. and Cicognola, C. and Stomrud, E. and Vanmechelen, E. and others}, title = {{Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays}}, journal = {Neurology}, year = {2021}, doi = {10.1212/wnl.0000000000012727}, pmid = {34493616}, url = {https://doi.org/10.1212/wnl.0000000000012727} } @article{mattssoncarlgren2021-33949133, author = {Mattsson-Carlgren, N. and Janelidze, S. and Bateman, R. J. and Smith, R. and Stomrud, E. and Serrano, G. E. and Reiman, E. M. and Palmqvist, S. and others}, title = {{Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau}}, journal = {EMBO molecular medicine}, year = {2021}, doi = {10.15252/emmm.202114022}, pmid = {33949133}, url = {https://doi.org/10.15252/emmm.202114022} } @article{pereira2022-37118533, author = {Pereira, J. B. and Janelidze, S. and Strandberg, O. and Whelan, C. D. and Zetterberg, H. and Blennow, K. and Palmqvist, S. and Stomrud, E. and others}, title = {{Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer's disease pathology}}, journal = {Nature aging}, year = {2022}, doi = {10.1038/s43587-022-00310-z}, pmid = {37118533}, url = {https://doi.org/10.1038/s43587-022-00310-z} } @article{ossenkoppele2021-34254442, author = {Ossenkoppele, R. and Reimand, J. and Smith, R. and Leuzy, A. and Strandberg, O. and Palmqvist, S. and Stomrud, E. and Zetterberg, H. and others}, title = {{Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers}}, journal = {EMBO molecular medicine}, year = {2021}, doi = {10.15252/emmm.202114398}, pmid = {34254442}, url = {https://doi.org/10.15252/emmm.202114398} } @article{zheng2024-37837382, author = {Zheng, L. and Rubinski, A. and Denecke, J. and Luan, Y. and Smith, R. and Strandberg, O. and Stomrud, E. and Ossenkoppele, R. and others}, title = {{Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease}}, journal = {Annals of neurology}, year = {2024}, doi = {10.1002/ana.26818}, pmid = {37837382}, url = {https://doi.org/10.1002/ana.26818} }